Skip to content

Validation of Laser Speckle Imaging

Comparison of Two Different Laser Speckle Contrast Imaging Devices For Assessing Microvascular Function and Validation With Cytocam-IDF Technique

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22543
Enrollment
15
Registered
2020-10-11
Start date
2019-12-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

None listed

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy human volunteers older than 18 years old who conform to following criteria • Should not have any disease now including flu • Should not have any disease known before • Should not be under any medication • Should not drink coffee or eat meal in two hours before the procedure

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: • Volunteer who does not meet any of the criteria above • <18 years old • Pregnants • Maastad Ziekenhuis employers/colleagues • Refusal to participate in the study or demand to end study for any reason

Design outcomes

Primary

MeasureTime frame
It is expected that the results from this project will provide new insights into the use and interpretation of different kind of LSCI devices in clinical practice and researches. •The primary objectives oTo test the comparebility of two different model LSCI devices in terms of baseline, supra- and infra-physiologic blood flows. oTo validate the non-validated LSCI device (Perimed (Järfälla, Sweden)) with a gold standart method (Cytocam-IDF). •

Secondary

MeasureTime frame
The secondary objectives o To assess the response of the LSCI devices during PORH o To understand differences between the different kind of LSCI devices in terms of physiologic responses o To assess and define normal blood flow values of the normal population.

Contacts

Public Contactannemieke dijkstra

Maasstad Ziekenhuis

annemiekedijkstra123@hotmail.com0615866102

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)